Nu Skin Enterprises, Inc. (NUS) Análisis de acciones

Descripción de la empresa

Nu Skin Enterprises, Inc. operates as a developer and distributor of beauty and wellness products, specifically focusing on skin care devices, cosmetics, and personal care items such as the ageLOC LumiSpa and Nu Skin RenuSpa iO. The company functions within the Consumer Defensive sector and the Household & Personal Products industry, positioning itself to meet consistent consumer needs for personal hygiene and aesthetic maintenance regardless of broader economic cycles. With a market capitalization of $358.50M and an annual revenue of $1.49B, the entity employs a workforce of 2,800 individuals across its global operations. These valuation and revenue figures suggest a mid-cap enterprise that maintains a significant operational footprint, yet the relatively low market cap compared to its revenue stream indicates a valuation structure that diverges from large-cap growth peers in the consumer staples space.

Salud financiera

The company reported a trailing twelve-month revenue of $1.49B and generated a net income of $160.20M, resulting in an EBITDA of $143.14M. The substantial difference between the $1.49B revenue and the $160.20M net income highlights a significant cost structure comprising cost of goods sold, operating expenses, and taxes that absorbs approximately 89.2% of top-line growth before reaching the bottom line. Free cash flow stands at $90.95M, providing the organization with substantial financial flexibility to fund capital expenditures, manage working capital, or pursue strategic acquisitions without immediate reliance on external financing. The gross margin is reported at 69.4%, indicating high pricing power or low cost of goods relative to sales; however, the operating margin of 6.3% reveals that overhead costs, including sales and administration, consume a considerable portion of the gross profit. The profit margin further narrows to 10.8%, reflecting the final profitability after all expenses, interest, and taxes are accounted for. On the balance sheet, the company holds $241.96M in cash against $308.64M in debt, resulting in a debt-to-equity ratio of 38.33, which characterizes a leveraged capital structure where debt obligations exceed cash reserves. Despite the leverage, the current ratio of 2.08 demonstrates robust short-term liquidity, as current assets are more than double current liabilities, ensuring the ability to meet immediate obligations. Return on Equity is calculated at 22.0%, signaling highly effective utilization of shareholder capital, while the Return on Assets stands at 4.0%, indicating the efficiency of the total asset base in generating profits relative to its size.

Evaluación de valoración

The trailing twelve-month P/E ratio is 2.29, while the forward P/E is projected at 5.56, implying that the market expects earnings to expand significantly in the coming year to justify the higher multiple. The price-to-book ratio of 0.44 suggests that the company's market capitalization is less than half of its book value, indicating a market discount relative to the net asset value rather than a premium. The price-to-sales ratio of 0.24 and an EV/EBITDA of 2.92 provide alternative valuation perspectives that emphasize the company's low valuation multiples compared to typical growth sectors. The stock has traded within a 52-week range between a high of $14.62 and a low of $5.32, and without the current specific price point provided in the facts, the relative position within this $9.30 range cannot be precisely quantified in terms of percentage deviation from the highs or lows. The beta of 1.07 indicates that the stock's price volatility moves in line with the broader market, neither significantly amplifying nor dampening systemic risk compared to the S&P 500.

Growth & Income

Revenue growth for the trailing twelve months is negative at -16.9%, while earnings growth data is not available in the current reporting period. The contraction in revenue suggests a decline in top-line sales compared to the prior year, whereas the absence of reported earnings growth prevents a direct comparison of profit expansion relative to sales shrinkage. As a dividend payer, the company offers a yield of 3.3% with a payout ratio of 7.6%, indicating that the dividend is paid out of a very small fraction of earnings, which theoretically allows for sustainability even if earnings fluctuate. The low payout ratio combined with the high revenue decline implies that the company retains the vast majority of its earnings rather than distributing them to shareholders. Overall, the growth and income profile presents a scenario of shrinking revenue supported by a leveraged balance sheet and a high dividend yield that relies on retained earnings rather than current distributable profits.